MBP and myeloid sarcoma: Thus, in the present study stable homo-β-amino acid containing analogs of MBP (85–99) were much more effective in suppressing the presentation of MBP (85–99) to auto-reactive T-cells subsequently down-modulating their activation and ultimately getting translated into mitigation of disease symptoms in a mouse model of MS.